About Oblique Therapeutics

Oblique Therapeutics is developing a new type of antibody-based medication for chronic pain and metastatic cancer. Oblique Therapeutics is an early stage innovation-driven pharmaceutical company aiming at developing transformative medicines against advanced and metastatic cancer.

Company Highlights
Year Founded

2015

icon-altEmployees

18

Location (HQ)

SWE

Since Last Funding

8 years 9 months

Monthly Website Visitors

9.7K

icon-altTotal Investment Amt

$2.5M

Last Funding Round

Series Unknown

Key Metrics

Senior Hires

NameLinkedin ProfilePositionDate Joined
John Doehttps://www.linkedin.com/in/johndoeCEOCEO
Jane Doehttps://www.linkedin.com/in/janedoeCTOCTO
John Smithhttps://www.linkedin.com/in/johnsmithCFOCFO
Jane Smithhttps://www.linkedin.com/in/janesmithCOOCOO
Get API access to complete private company database with growth metrics from 15 sources

Health Care

Pharmaceutical

Pharmaceutical Manufacturing

Pharmaceuticals

Hospital